Da Song Wang
Director/Board Member chez ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.
Profil
Da Song Wang is currently a Non-Executive Director at Zylox-Tonbridge Medical Technology Co., Ltd.
and a Partner at OrbiMed Advisors Private Equity.
He previously served as a Non-Executive Director at 3SBio, Inc. and EC Healthcare, and as an Executive Director at Morgan Stanley Capital Partners (Private Equity) and Managing Director at UBS Asset Management (Infrastructure).
He also held a senior position at Credit Suisse (Hong Kong) Ltd.
and was a Non-Executive Director at Apollomics, Inc. Dr. Wang holds a doctorate from The Johns Hopkins University, an MBA from New York University, and an undergraduate degree from the University of Southern Maine.
Postes actifs de Da Song Wang
| Sociétés | Poste | Début |
|---|---|---|
| ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD. | Director/Board Member | 13/10/2020 |
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London. | Private Equity Investor | 01/09/2019 |
Anciens postes connus de Da Song Wang
| Sociétés | Poste | Fin |
|---|---|---|
| EC HEALTHCARE | Director/Board Member | 19/07/2021 |
| 3SBIO INC. | Director/Board Member | 08/10/2019 |
UBS Asset Management (Infrastructure)
 UBS Asset Management (Infrastructure) Investment ManagersFinance UBS Asset Management (Infrastructure) is founded in 2007.Headquartered in United Kingdom. | Private Equity Investor | 01/07/2014 |
Morgan Stanley Capital Partners (Private Equity)
 Morgan Stanley Capital Partners (Private Equity) Investment ManagersFinance Morgan Stanley Capital Partners (Morgan Stanley Capital) is a private equity subsidiary of Morgan Stanley founded in 1985. The firm is headquartered in New York. | Private Equity Investor | 01/05/2011 |
Credit Suisse (Hong Kong) Ltd.
 Credit Suisse (Hong Kong) Ltd. Investment Banks/BrokersFinance Credit Suisse (Hong Kong) Ltd. (CSHK) is a securities brokerage firm headquartered Hong Kong. The firm is a subsidiary of Credit Suisse AG, which is owned by Credit Suisse Group AG (SWX: CSGN; ADR: CS) in Switzerland. CSHK provides corporate and institutional investors with sales, trading, financing, prime services, and market-making in global equities, as well as equities-related securities, options, futures, risk management, and hedging products. Their client-focused platform offers issuer and investor clients access to distribution, trading, and origination capabilities across various markets globally. | Corporate Officer/Principal | - |
Formation de Da Song Wang
| The Johns Hopkins University | Doctorate Degree |
| New York University | Masters Business Admin |
| University of Southern Maine | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| 3SBIO INC. | Health Technology |
| EC HEALTHCARE | Health Services |
| ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD. | Health Technology |
| Entreprise privées | 5 |
|---|---|
Credit Suisse (Hong Kong) Ltd.
Credit Suisse (Hong Kong) Ltd. Investment Banks/BrokersFinance Credit Suisse (Hong Kong) Ltd. (CSHK) is a securities brokerage firm headquartered Hong Kong. The firm is a subsidiary of Credit Suisse AG, which is owned by Credit Suisse Group AG (SWX: CSGN; ADR: CS) in Switzerland. CSHK provides corporate and institutional investors with sales, trading, financing, prime services, and market-making in global equities, as well as equities-related securities, options, futures, risk management, and hedging products. Their client-focused platform offers issuer and investor clients access to distribution, trading, and origination capabilities across various markets globally. | Finance |
OrbiMed Advisors Private Equity
OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London. | Finance |
Morgan Stanley Capital Partners (Private Equity)
Morgan Stanley Capital Partners (Private Equity) Investment ManagersFinance Morgan Stanley Capital Partners (Morgan Stanley Capital) is a private equity subsidiary of Morgan Stanley founded in 1985. The firm is headquartered in New York. | Finance |
UBS Asset Management (Infrastructure)
UBS Asset Management (Infrastructure) Investment ManagersFinance UBS Asset Management (Infrastructure) is founded in 2007.Headquartered in United Kingdom. | Finance |
Apollomics, Inc. (United States)
 Apollomics, Inc. (United States) BiotechnologyHealth Technology Apollomics, Inc. operates as a sciences oncology company. It is a biotechnology company focusing on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company was founded by Sanjeev Gurunath Redkar and Guo-Liang Yu on May 21, 2015 and is headquartered in Foster City, CA. | Health Technology |
